XCOPRI is a new option to treat adults with partial-onset seizures, which is an often difficult-to-control condition. The safety and efficacy of XCOPRI  was established in two randomized, double-blind, placebo-controlled studies that enrolled 655 adults. In these studies, patients had partial-onset seizures with or without secondary generalization for an average of approximately 24 years and median seizure frequency of 8.5 seizures per 28 days during an 8-week baseline period. During the trials, XCOPRI reduced the percent of seizures per 28 days compared with the placebo group.

 

S.T.E.P.S. Discussion Guide
An image Download File

With the right S.T.E.P.S., you can have stronger conversations with your healthcare provider and work together to reach your goals.
XCOPRI Flashcard
An image Download File 		Discover the possibility of zero seizures with new XCOPRI
DDI Tool
An image Download File 		Getting your patients started on Xcopri…
PI
An image Download File 		Xcopri Prescribing Information